These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 2284487

  • 1. [The participation of platelet-activating factor and cytokines in the pathogenesis of glomerular damage].
    Egido J, Gómez-Chiarri M, Lerma JL, González E, Maestre C, Ortiz A, Hernando L.
    Rev Clin Esp; 1990; 187(3):137-43. PubMed ID: 2284487
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. The potential role of inflammatory and fibrogenic cytokines in the glomerular diseases.
    Ortiz A, Gómez-Chiarri M, Alonso J, Bustos C, Gómez-Guerrero C, López-Armada MJ, Gómez-Garre D, Palacios I, Ruíz-Ortega M, Gutierrez S.
    J Lipid Mediat Cell Signal; 1994 Feb; 9(1):55-74. PubMed ID: 8032716
    [Abstract] [Full Text] [Related]

  • 4. Interactive effects of tumor necrosis factor and platelet-activating factor in the pathogenesis of glomerular injury.
    Camussi G.
    Lab Invest; 1994 Apr; 70(4):435-6. PubMed ID: 8176883
    [No Abstract] [Full Text] [Related]

  • 5. Involvement of cytokines and platelet-activating factor in renal pathology.
    Camussi G, Tetta C, Bussolino F, Andres G, Turello E, Baglioni C.
    J Lipid Mediat; 1990 Apr; 2 Suppl():S203-13. PubMed ID: 2133283
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Eicosanoids and glomerular disease].
    Kuroda M.
    Nihon Rinsho; 1990 Jun; 48(6):1270-5. PubMed ID: 2384974
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. [Pathogenesis of the idiopathic nephrotic syndrome].
    Robeva R.
    Vutr Boles; 1988 Jun; 27(5):9-14. PubMed ID: 3062902
    [No Abstract] [Full Text] [Related]

  • 12. Enhanced glomerular thromboxane A2 mediates some pathophysiologic effect of platelet-activating factor in rabbit nephrotoxic nephritis: evidence from biochemical measurements and inhibitor trials.
    Macconi D, Benigni A, Morigi M, Ubiali A, Orisio S, Livio M, Perico N, Bertani T, Remuzzi G, Patrono C.
    J Lab Clin Med; 1989 May; 113(5):549-60. PubMed ID: 2541212
    [Abstract] [Full Text] [Related]

  • 13. An update on glomerular disease in the elderly.
    Glassock RJ.
    Clin Geriatr Med; 2013 Aug; 29(3):579-91. PubMed ID: 23849009
    [Abstract] [Full Text] [Related]

  • 14. [Synthesis and role of cytokines in glomerular pathology].
    Baud L, Fouqueray B, Philippe C, Perez J.
    Nephrologie; 1991 Aug; 12(3):151-6. PubMed ID: 1922656
    [No Abstract] [Full Text] [Related]

  • 15. Tumor necrosis factor in renal injury.
    Baud L, Ardaillou R.
    Miner Electrolyte Metab; 1995 Aug; 21(4-5):336-41. PubMed ID: 7565482
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Glomerular permeability in the nephrotic syndrome.
    Schreiner GE.
    Trans Am Clin Climatol Assoc; 1969 Aug; 80():96-107. PubMed ID: 5804779
    [No Abstract] [Full Text] [Related]

  • 18. Inhibiting inflammatory cytokines.
    Kluth DC, Rees AJ.
    Semin Nephrol; 1996 Nov; 16(6):576-82. PubMed ID: 9125802
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.